RIGEL PHARMACEUTICALS INC
For the period ended Dec 31, 2025. Filed Mar 3, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 3, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
We lease a 13,670 rentable square feet office space located at 611 Gateway Boulevard, Suite 900, South San Francisco, California, which lease expires in July 2027. The lease was originally entered into with 611 Gateway Center LLP (611 Gateway). In January 2026, Healthpeak OP, LLC (Healthpeak) assumed ownership of the property following its acquisition from 611 Gateway. This facility currently serves as our corporate headquarters. We believe the facility is in good operating condition and is adequate to meet our current and near-term operational needs.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.